Baricitinib Plus Glucocorticoid for Eosinophilia in IgG4-RD

Clinical trial NCT05781516 · UNKNOWN

Trial details

NCT number: NCT05781516
Sponsor: Wen Zhang
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

IgG4-related Disease With Eosinophilia

Start date: 2023-01-20
Primary completion: 2024-06-01
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.